HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evgenija A Djurendić Selected Research

Prostatic Neoplasms (Prostate Cancer)

6/2018Evaluation of A-ring fused pyridine d-modified androstane derivatives for antiproliferative and aldo-keto reductase 1C3 inhibitory activity.
10/2016Preselection of A- and B- modified d-homo lactone and d-seco androstane derivatives as potent compounds with antiproliferative activity against breast and prostate cancer cells - QSAR approach and molecular docking analysis.
4/2015Synthesis, structural analysis and antitumor activity of novel 17α-picolyl and 17(E)-picolinylidene A-modified androstane derivatives.
2/2015Synthesis and anticancer cell potential of steroidal 16,17-seco-16,17a-dinitriles: identification of a selective inhibitor of hormone-independent breast cancer cells.
10/2014Non-linear assessment of anticancer activity of 17-picolyl and 17-picolinylidene androstane derivatives--chemometric guidelines for further syntheses.
12/201317(E)-picolinylidene androstane derivatives as potential inhibitors of prostate cancer cell growth: antiproliferative activity and molecular docking studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Evgenija A Djurendić Research Topics

Disease

6Prostatic Neoplasms (Prostate Cancer)
06/2018 - 12/2013
3Neoplasms (Cancer)
06/2018 - 02/2015
3Breast Neoplasms (Breast Cancer)
10/2016 - 02/2015
2Colonic Neoplasms (Colon Cancer)
06/2018 - 04/2015
2Adenocarcinoma
10/2016 - 04/2015
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2018
1Necrosis
11/2015
1Adenocarcinoma of Lung
04/2015
1Carcinoma (Carcinomatosis)
04/2015
1Dehydration (Water Stress)
01/2007

Drug/Important Bio-Agent (IBA)

5androstaneIBA
06/2018 - 12/2013
3Estrogen ReceptorsIBA
11/2015 - 02/2015
2LactonesIBA
06/2018 - 10/2016
2abirateroneIBA
10/2016 - 12/2013
2Androgen Receptors (Androgen Receptor)IBA
02/2015 - 10/2014
2Aromatase (CYP19)IBA
02/2015 - 12/2013
1propargylamineIBA
06/2018
1EnzymesIBA
06/2018
1pyridineIBA
06/2018
1Aldo-Keto ReductasesIBA
06/2018
1SteroidsIBA
06/2018
1Estrogens (Estrogen)FDA Link
10/2016
1AndrogensIBA
10/2016
1compound 17IBA
04/2015
1Hormones (Hormone)IBA
02/2015
1Mixed Function Oxygenases (Monooxygenases)IBA
02/2015
1NitrilesIBA
02/2015
1LigandsIBA
02/2015
1AndrostanesIBA
12/2013
1Pharmaceutical PreparationsIBA
12/2013
1dichlorodicyanobenzoquinoneIBA
01/2007